Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Photoproteins are a specialized class of bioluminescent proteins primarily found in marine organisms such as jellyfish (e.g., Aequorea victoria) and ctenophores. Unlike traditional luciferases, photoproteins like Aequorin are unique because they are "pre-charged" with their substrate, coelenterazine, and oxygen, existing as a stable peroxy-coelenterazine complex until triggered by calcium ions (UniProt P02592). This trigger-to-light mechanism makes them exceptionally sensitive tools for monitoring intracellular calcium flux, which is a critical second messenger in many signaling pathways. In the pharmaceutical industry, photoproteins are widely employed in high-throughput screening (HTS) assays to identify agonists or antagonists of G-protein coupled receptors (GPCRs) and ion channels (PubChem, CID 10186938). While they are not therapeutic targets found in the human genome, they are integral to the drug discovery process and have been marketed as dietary supplements for cognitive health, although such claims remain a subject of regulatory scrutiny (FDA, 2017). Their primary value lies in their role as high-precision biological reporters rather than as sites for direct drug intervention.
Photoproteins function by forming a stable enzyme-substrate complex consisting of the apoprotein, the luminophore coelenterazine, and molecular oxygen. Upon binding of specific ions, typically calcium (Ca2+), the protein undergoes a conformational change that triggers the oxidation of coelenterazine into coelenteramide, releasing CO2 and emitting a flash of blue light (approx. 470 nm).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Photoprotein.